InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
9
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+31.9%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Galluppi Stefan, Chief Technology Officer. Officer active across 2 companies, notably LifeMD, Inc.. Aggregated, 13 filings have been recorded. Breakdown: 9 buys · 0 sell. Total volume traded: €125k. Activity tracked since 19 May 2021. The latest transaction was disclosed on 31 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
30,000 shares0Common StockSEC:0000912282-25-000363:0
30,000 shares0Common StockSEC:0000912282-25-000282:0
60,000 shares0Common SharesSEC:0000912282-25-000265:0
3,000 shares@ US$4.9314.5% of flowCommon StockSEC:0001362118-24-000022:0
Ideal exit: 8 Jun 2025 (T+270)
30,000 shares0Common StockSEC:0001362118-24-000010:0
4,608 shares@ US$2.1710.0% of flowCommon Stock, par value $0.01SEC:0001362118-23-000035:0
Ideal exit: 17 Feb 2024 (T+270)
10,000 shares@ US$2.1721.7% of flowCommon Stock, par value $0.01SEC:0001362118-23-000032:0
Ideal exit: 17 Feb 2024 (T+270)
100 shares@ US$4.790.0003% mcap0.8% of flowCommon Stock, par value $0.01SEC:0001362118-21-000043:0
Ideal exit: 14 Aug 2022 (T+270)
100 shares@ US$4.790.5% of flowCommon Stock, par value $0.01SEC:0001362118-21-000043
Ideal exit: 14 Aug 2022 (T+270)
2,097 shares@ US$4.550.0051% mcap16.7% of flowCommon Stock, par value $0.01SEC:0001362118-21-000042:0
Ideal exit: 12 Aug 2022 (T+270)
2,097 shares@ US$4.559.0% of flowCommon Stock, par value $0.01SEC:0001362118-21-000042
Ideal exit: 12 Aug 2022 (T+270)
3,796 shares@ US$10.40100.0% of flowCommon Stock, par value $0.01SEC:0001362118-21-000014
Ideal exit: 13 Feb 2022 (T+270)
3,796 shares@ US$10.400.020% mcap64.9% of flowCommon Stock, par value $0.01SEC:0001362118-21-000014:0
Ideal exit: 13 Feb 2022 (T+270)
13 of 13 declarations
About Galluppi Stefan
Stefan Galluppi is the Chief Technology Officer of LifeMD, Inc. He oversees technological development and innovation within the company. His role is essential in ensuring that the organization remains at the forefront of technological advancements.
